Germline predisposition to soft tissue sarcoma

被引:5
作者
Vagher, Jennie [1 ]
Dietz, Matthew S. [2 ]
Schiffman, Joshua D. [1 ,3 ]
Kohlmann, Wendy [1 ,2 ]
Maese, Luke [1 ,2 ]
机构
[1] Univ Utah, Dept Populat Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[2] Univ Utah, Div Hematol Oncol, Primary Childrens Hosp, Salt Lake City, UT 84112 USA
[3] Peel Therapeut Inc, Altitude Lab, Salt Lake City, UT 84108 USA
基金
美国国家卫生研究院;
关键词
Genetic; soft tissue sarcoma; Li-Fraumeni syndrome; cancer predisposition syndrome; NERVE SHEATH TUMORS; GASTROINTESTINAL STROMAL TUMORS; LI-FRAUMENI SYNDROME; SUCCINATE-DEHYDROGENASE; CLINICAL SPECTRUM; DESMOID TUMORS; YOUNG-CHILDREN; EWINGS-SARCOMA; MUTATIONS; RISK;
D O I
10.20517/2394-4722.2022.31
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Soft tissue sarcoma (STS) most often occurs sporadically, but can also arise in the setting of a germline cancer predisposition syndrome (CPS). There is significant diversity amongst STS diagnoses as these tumors exhibit a variety of histologies, occur in all age groups, and can occur in any location in the body. This diversity is also reflected in the many known associated germline cancer predisposition associations. Some STS diagnoses, such as anaplastic rhabdomyosarcoma, are associated with high heritability and other STS, such as Ewing sarcoma, are notably absent from known CPS. Recognizing when a STS is more likely to be hereditary can influence clinical management. Individuals diagnosed with STS due to CPS may be at risk for other malignancies and should undergo additional surveillance for early detection. Additionally, family members should undergo genetic testing as they also may be at risk to develop STS and other CPS-associated malignancies. Some underlying cancer predisposition diagnoses may have implications for the treatment of a concurrent malignancy as in the case of PARP inhibitor therapy in the setting of homologous recombination deficiency. This review summarizes current knowledge of selected STS and their associations with CPS.
引用
收藏
页数:16
相关论文
共 98 条
  • [1] Abbott D, 2015, AACR
  • [2] Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2
    Agresta, Laura
    Salloum, Ralph
    Hummel, Trent R.
    Ratner, Nancy
    Mangano, Francesco T.
    Fuller, Christine
    McMasters, Richard L.
    Pater, Luke
    Jones, Blaise V.
    Szabo, Sara
    Pressey, Joseph G.
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 (02)
  • [3] Malignant peripheral nerve sheath tumors - Prognostic factors and survival in a series of patients treated at a single institution
    Anghileri, Matteo
    Miceli, Rosalba
    Fiore, Marco
    Mariani, Luigi
    Ferrari, Andrea
    Mussi, Chiara
    Lozza, Laura
    Collini, Paola
    Olmi, Patrizia
    Casali, Paolo G.
    Pilotti, Silvana
    Gronchi, Alessandro
    [J]. CANCER, 2006, 107 (05) : 1065 - 1074
  • [4] DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing
    Apellaniz-Ruiz, Maria
    McCluggage, W. Glenn
    Foulkes, William D.
    [J]. GENES CHROMOSOMES & CANCER, 2021, 60 (03) : 217 - 233
  • [5] Monogenic and polygenic determinants of sarcoma risk: an international genetic study
    Ballinger, Mandy L.
    Goode, David L.
    Ray-Coquard, Isabelle
    James, Paul A.
    Mitchell, Gillian
    Niedermayr, Eveline
    Puri, Ajay
    Schiffman, Joshua D.
    Dite, Gillian S.
    Cipponi, Arcadi
    Maki, Robert G.
    Brohl, Andrew S.
    Myklebost, Ola
    Stratford, Eva W.
    Lorenz, Susanne
    Ahn, Sung-Min
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Shanley, Sue
    Beshay, Victoria
    Randall, Robert Lor
    Judson, Ian
    Seddon, Beatrice
    Campbell, Ian G.
    Young, Mary-Anne
    Sarin, Rajiv
    Blay, Jean-Yves
    O'Donoghue, Sean I.
    Thomas, David M.
    [J]. LANCET ONCOLOGY, 2016, 17 (09) : 1261 - 1271
  • [6] Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic
    Boikos, Sosipatros A.
    Pappo, Alberto S.
    Killian, J. Keith
    LaQuaglia, Michael P.
    Weldon, Chris B.
    George, Suzanne
    Trent, Jonathan C.
    von Mehren, Margaret
    Wright, Jennifer A.
    Schiffman, Josh D.
    Raygada, Margarita
    Pacak, Karel
    Meltzer, Paul S.
    Miettinen, Markku M.
    Stratakis, Constantine
    Janeway, Katherine A.
    Helman, Lee J.
    [J]. JAMA ONCOLOGY, 2016, 2 (07) : 922 - 928
  • [7] Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
    Bougeard, Gaelle
    Renaux-Petel, Mariette
    Flaman, Jean-Michel
    Charbonnier, Camille
    Fermey, Pierre
    Belotti, Muriel
    Gauthier-Villars, Marion
    Stoppa-Lyonnet, Dominique
    Consolino, Emilie
    Brugieres, Laurence
    Caron, Olivier
    Benusiglio, Patrick R.
    Bressac-de Paillerets, Brigitte
    Bonadona, Valerie
    Bonaiti-Pellie, Catherine
    Tinat, Julie
    Baert-Desurmont, Stephanie
    Frebourg, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) : 2345 - U33
  • [8] Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
    Bourdeaut, Franck
    Lequin, Delphine
    Brugieres, Laurence
    Reynaud, Stephanie
    Dufour, Christelle
    Doz, Francois
    Andre, Nicolas
    Stephan, Jean-Louis
    Perel, Yves
    Oberlin, Odile
    Orbach, Daniel
    Bergeron, Christophe
    Rialland, Xavier
    Freneaux, Paul
    Ranchere, Dominique
    Figarella-Branger, Dominique
    Audry, Georges
    Puget, Stephanie
    Evans, D. Gareth
    Ferreres Pinas, Joan Carles
    Capra, Valeria
    Mosseri, Veronique
    Coupier, Isabelle
    Gauthier-Villars, Marion
    Pierron, Gaelle
    Delattre, Olivier
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (01) : 31 - 38
  • [9] Extracranial rhabdoid tumours: what we have learned so far and future directions
    Brennan, Bernadette
    Stiller, Charles
    Bourdeaut, Franck
    [J]. LANCET ONCOLOGY, 2013, 14 (08) : E329 - E336
  • [10] Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
    Bright, Chloe J.
    Hawkins, Mike M.
    Winter, David L.
    Alessi, Daniela
    Allodji, Rodrigue S.
    Bagnasco, Francesca
    Bardi, Edit
    Bautz, Andrea
    Byrne, Julianne
    Feijen, Elizabeth A. M.
    Fidler, Miranda M.
    Garwicz, Stanislaw
    Grabow, Desiree
    Gudmundsdottir, Thorgerdur
    Guha, Joyeeta
    Haddy, Nadia
    Jankovic, Momcilo
    Kaatsch, Peter
    Kaiser, Melanie
    Kuehni, Claudia E.
    Reulen, Raoul C.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (06): : 649 - 660